Streetbeat News

Products Services

AENT

Alliance Entertainment's division Mill Creek Entertainment, in partnership with Pinnacle Peak Pictures and Tread Lively, announced successful pre-sales for the home entertainment release of THE BLIND. The film topped Amazon's pre-sales across all movies & TV, and is #1 in overall DVD sales and in the Faith/Spirituality category. It grossed over $17 million at the box office and is Fathom Events' highest-grossing release ever. THE BLIND, which tells the story of Phil Robertson's early life, is available on Digital, DVD, and Blu-ray.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:37 pm

MOND

Mondee Holdings, Inc. (NASDAQ:MOND) has acquired Purplegrids, an AI company specializing in enterprise AI platforms. The acquisition, completed on November 13th in an all-share transaction, aims to enhance Mondee's AI capabilities in the travel sector. Purplegrids' founders and their team, with backgrounds from companies like Apple and PayPal, will join Mondee. The acquisition is expected to strengthen Mondee's AI travel platform and maintain its first-mover advantage in AI within the travel industry.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:36 pm

KZIA

Kazia Therapeutics Limited (KZIA) released an abstract for the PNOC022 clinical study, which will be presented at the Society of Neuro-Oncology 2023 Annual Meeting. The study shows promising results for paxalisib in treating Diffuse Midline Glioma (DMG), with a median overall survival of 16.5 months compared to the standard of care's 8-11 months. Paxalisib has received Rare Pediatric Disease Designation from the FDA, potentially leading to a priority review voucher.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:35 pm

PAVS

Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) has signed a software development agreement with BlueLine Studios Inc. to develop the AI-generated content game, Hollywood Sunshine. BlueLine, a portfolio company of Caravan Digital L.P., will work on creating a social gaming platform with celebrity involvement. Paranovus will pay up to $1.9 million in development fees and retain exclusive rights to the project, excluding background technology. The PC version is expected in Q2 2024, with an iOS version potentially following in Q3 2024. The partnership aims to leverage increasing demand for AIGC in the gaming industry. Paranovus is also considering acquiring BlueLine but is currently prioritizing the development project.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:34 pm

FEMY

PMCB

PharmaCyte Biotech, Inc. has invested $5 million in Femasys, Inc., a biomedical company focused on women's health. This investment is part of PharmaCyte's strategy to utilize its cash position to create shareholder value. PharmaCyte's interim CEO, Josh Silverman, will join Femasys' Board of Directors. Femasys is developing a portfolio of in-office solutions for women's health, including a late-stage product candidate for permanent birth control and FDA-cleared infertility treatment and diagnostic products.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:34 pm

YTEN

The USDA-APHIS has approved Yield10 Bioscience's glufosinate tolerant Camelina for planting and breeding in the U.S. This regulatory milestone allows Yield10 to advance its product development and commercialization efforts for this genetically modified crop, which is designed to be resistant to certain herbicides, potentially offering farmers a new option for managing weeds and improving yields.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:32 pm

KNDI

Kandi Technologies Group, Inc. has announced the arrival of its first batch of 500 all-electric mini golf carts in the United States. The carts, designed by American professionals and manufactured by Kandi, feature electric telescopic functionality and a distinctive design. Kandi anticipates that these compact, versatile, and reasonably priced carts will be well-received by consumers and become a popular product in their lineup.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:32 pm

DDD

3D Systems (NYSE:DDD) has received FDA 510(k) clearance for its NextDent Base material for 3D printing denture bases. This third-generation material offers high break resistance, accurate printing, and repeatable results. It is part of 3D Systems' portfolio of 30 unique NextDent resins, the largest from any dental 3D printing material supplier. The material has received positive feedback from dental professionals and is expected to contribute to the growing 3D-printed denture market, which is anticipated to reach over $2 billion by 2028. NextDent Base is available in four colors and is part of 3D Systems' digital dental workflow, which aims to improve speed, productivity, efficiency, and patient experience.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:31 pm

CMMB

Chemomab Therapeutics Ltd (NASDAQ:CMMB) stock surged after the FDA granted Fast Track designation to CM-101 for primary sclerosing cholangitis (PSC). Fast Track can lead to more frequent FDA interactions, priority review, and accelerated approval. CM-101 is a monoclonal antibody targeting CCL24, associated with PSC. The Phase 2 SPRING trial is ongoing, with top-line results expected in the second half of 2024. CMMB shares jumped 54.10% in premarket trading.

Portfolio Pulse from Vandana Singh

November 15, 2023 | 1:29 pm

ALAR

Alarum Technologies Ltd. (ALAR), through its subsidiary NetNut Ltd., has been granted a U.S. patent for an innovative anonymous proxying method. The patent, No. 11,818,104, enhances traditional proxy services by using a 'reflector' method that avoids typical bottlenecks and security risks, providing a faster and more secure internet connection. This development strengthens Alarum's intellectual property portfolio and market position, offering a competitive advantage in internet access and web data collection.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 1:27 pm